Using cervical fluid obtained during routine Pap tests, scientists at the Johns Hopkins Kimmel Cancer Center have developed a test to detect ovarian and endometrial cancers. In a pilot study, the “PapGene” test, which relies on genomic sequencing of cancer-specific mutations, accurately detected all 24 (100 percent) endometrial cancers and nine of 22 (41 percent) ovarian cancers. Results of the experiments are published in the January 9 issue of the journal, Science Translational Medicine.
The investigators note that larger scale studies are needed before clinical implementation can begin, but they believe the test has the potential to pioneer genomic-based cancer screening tests.
{iframe}http://www.sciencecodex.com/johns_hopkins_scientists_use_pap_test_fluid_to_detect_ovarian_endometrial_cancers-104866{/iframe}